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Abstract
Protein-protein interactions through short linear motifs (SLiMs) are an emerging concept that is different from interactions
between globular domains. The SLiMs encode a functional interaction interface in a short (three to ten residues) poorly
conserved sequence. This characteristic makes them much more likely to arise/disappear spontaneously via mutations, and
they may be more evolutionarily labile than globular domains. The diversity of SLiM composition may provide functional
diversity for a viral protein from different viral strains. This study is designed to determine the different SLiM compositions of
ribonucleoproteins (RNPs) from influenza A viruses (IAVs) from different hosts and with different levels of virulence. The 96
consensus sequences (regular expressions) of SLiMs from the ELM server were used to conduct a comprehensive analysis of
the 52,513 IAV RNP sequences. The SLiM compositions of RNPs from IAVs from different hosts and with different levels of
virulence were compared. The SLiM compositions of 845 RNPs from highly virulent/pandemic IAVs were also analyzed. In
total, 292 highly conserved SLiMs were found in RNPs regardless of the IAV host range. These SLiMs may be basic motifs
that are essential for the normal functions of RNPs. Moreover, several SLiMs that are rare in seasonal IAV RNPs but are
present in RNPs from highly virulent/pandemic IAVs were identified. The SLiMs identified in this study provide a useful
resource for experimental virologists to study the interactions between IAV RNPs and host intracellular proteins. Moreover,
the SLiM compositions of IAV RNPs also provide insights into signal transduction pathways and protein interaction networks
with which IAV RNPs might be involved. Information about SLiMs might be useful for the development of anti-IAV drugs.
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Introduction
Protein-protein interactions can be categorized into the
following four classes: domain-domain interactions, mutual fit
interactions, induced fit interactions and linear motif-domain
interactions [1]. The binding site for linear motif-domain
interactions is a short peptide of only a few (three to ten) residues
that is called a ‘‘short linear motif’’ (SLiM) [1]. Three character-
istics differentiate SLiMs from globular domains. The first
characteristic is the ability of SLiMs to encode a functional
interaction interface in a short (three to ten residues) and often
poorly conserved sequence. The short length of the motifs also
makes them much more likely to arise/disappear spontaneously
via mutations, which make them more evolutionarily labile (i.e.
likely to appear de novo in unrelated protein sequences) [1]. The
second feature of SLiMs is that the richness of potential motif-
domain interactions is higher than the domain-domain interac-
tions within a given length of sequence. The third characteristic of
SLiMs is that because only a small number of residues are
involved, the interactions tend to be transient and have low
binding affinities. Therefore, they are well suited for mediating
functions that require a fast response to changing stimuli, such as
interactions between SH2 motifs (which binds a phosphorylated
tyrosine) and phosphorylation sites on its binding partners. These
three characteristics may provide a flexible molecular basis for fast
evolved proteins of RNA viruses with great versatility.
Several pioneering studies were significant for the character-
ization of SLiMs in viral proteins. Davey et al. collected 52
experimentally validated SLiMs present in viral proteins [2].
These examples of viral SLiMs are present in highly studied
viral proteins that are responsible for relevant diseases, such as
cancers (human papillomavirus, Epstein-Barr virus, human T-
cell lymphotropic virus and adenovirus), immunodeficiency
(HIV) or the flu (influenza). Currently, a comprehensive SLiM
database has been established that is called the Eukaryotic
Linear Motif (ELM) Resource for Functional Sites in Proteins
[3]. Based on the motif patterns provided in the ELM database,
computational analysis can be performed to identify high
potential SLiMs in target proteins and can reduce the arduous
and high cost laboratory procedures that are required to identify
them.
The ribonucleoprotein (RNP) complex of influenza A virus
(IAV), which is composed of the PA, PB1, PB2 and NP proteins, is
essential for virus replication in cells. The RNP complex replicates
the segments of the RNA virus genome and transcribes its genes
[4]. Moreover, the RNP complex affects the evolution of IAV
through its error-prone RNA polymerase, which produces variants
of the viral proteins, including the HA, NA and the RNP
themselves. Therefore, virus strains that are better adapted to a
new host species are created [5]. Additionally, the RNP complex
represents a promising drug target because its activities are distinct
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its biomedical importance, the absence of detailed SLiM
information of the RNPs has limited our mechanistic understand-
ing of RNP functions and the ability to design better drugs.
The present study sought to gain a deeper understanding of
IAV RNP-host interactions that affect RNP activity in human
cells. Using a functional proteomics approach, 96 SLiM consensus
sequences (regular expressions) from the ELM server [3] were used
to perform a systemic and comprehensive analysis of IAV RNPs. A
comparative study of the SLiM composition of RNPs from IAVs
from different hosts and highly virulent/pandemic (HP) IAV
strains was performed. Several SLiMs, including highly conserved
SLiMs, IAV host specific SLiMs and/or HP IAV specific SLiMs,
that might affect RNP function were identified. The results of this
study not only provide information on the SLiM compositions of
IAV RNPs but also provide insights into the signal transduction
pathways and protein interaction networks which IAV RNPs
might be involved in.
Materials and Methods
Data
In total 63,237 sequences from IAV RNPs were retrieved from
the NCBI Influenza Database. After checking for completeness by
assessing the N-terminus and the length, 52,505 IAV RNP
sequences were used in this study. This data set includes 18,952,
29,230 and 4,323 RNP sequences from IAVs from avian, human
and mammalian hosts, respectively (Information S1). Hosts of the
avian and mammalian IAVs are listed in Information S2. A set of
845 RNP sequences (Information S3) from highly virulent/
pandemic (HP) IAVs, including the 1918 H1N1 IAV from the
‘‘Spanish Flu’’, the H2N2 IAV from the 1957 outbreak, the H3N2
IAV from the 1957 outbreak, the H1N1 IAV from the 1977
Russia outbreak, the 2009 H1N1 IAV from the ‘‘swine flu’’, the
H5N1 IAV from the 1997 Hong Kong outbreak and the 2004–
2008 highly pathogenic H5N1IAVs from Vietnam, Indonesia and
Thailand were analysed.
Information regarding the SLiMs was retrieved from the ELM
server (the Eukaryotic Linear Motif Resource for Functional Sites
in Proteins) [3]. SLiMs were classified into four types: protease
cleavage sites (prefix CLV), protein motif interacting/binding sites
(prefix LIG), posttranslational modification sites (prefix MOD) and
subcellular targeting signals (prefix TRG) [3]. In total, 96 SLiMs
that are each supported by more than five real sequences were
used in this study and are listed in Information S4.
Statistical Methods
The tests for differences among k proportions were performed as
follows [7]:
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The log-likelihood ratio tests for independence were performed
as follows [7]:
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The Shannon entropy H was introduced by Shannon as a
measurement of uncertainty [8]. This method has been applied to
measure the diversity of amino acids to identify biologically
important amino acids in viral proteins from Papillomavirus [9],
West Nile virus [10], HCV [11] and IAV [12,13,14]. The
Shannon diversity index of each SLiM was computed by the
formula:
H~{
P
plog p, where p is the proportion of each SLiM [7].
Identity Distributions of Pairwise Alignments. For a
given a SLiM, all sequences harbor the SLiM from each host class
were used to perform pairwise alignments and to compute the
identity of each pair. For example, the SLiM LIG_PT-
B_Apo_2_328 was identified in 4777, 4715 and 746 PA sequences
from avian, human and mammalian IAVs, respectively. The
11,407,476 identities from (47776(477721)/2) pairwise align-
ments were computed using PA sequences from avian IAVs.
Similarly, the 11,113,255 identities from (47156(471521)/2)
pairwise alignments were computed using PA sequences from
human IAVs. The 277,885 identities from (7466(74621)/2)
pairwise alignments were computed using PA sequences from
mammalian IAVs. Then, the distributions of the three sets of
identities were plotted together.
Perl Programming
The computer programs that were used in this study for data
manipulation and pattern (regular expression) match were written
by the author using the Perl programming language. The program
used for this data analysis is available on request.
Results
An overview of the motif-based diversity of IAV RNP
sequences
In total, 96 SLiM consensus sequences (regular expressions)
were retrieved from the ELM server and were used to analyze the
diversity of SLiM compositions for 52,505 IAV RNP sequences
(Information S1). For each RNP, the occurrence of a SLiM at a
position in the RNP is computed by the number of the RNP
sequences with the SLiM at a given position divided by total
number of the RNP sequences. For example, 7,222 PA protein
sequences from human IAVs were used in this study. A SLiM with
an occurrence of 1% for the PA protein from human IAVs means
that 72 of the 7,222 PA protein sequences from human IAVs have
the SLiM at the same position. As shown in Figure 1A, 1C, 1E and
1G, the identified SLiMs can be divided into the following three
categories: an occurrence of greater than 90%, an occurrence
between 90–10% and an occurrence of less than 10%. The group
of SLiMs with an occurrence of over 90% (highly conserved) may
be basic functional motifs for each RNP. A small fraction of the
SLiMs with an occurrence between 90–10% forms the second
group which represents partially conserved motifs (conserved in a
subset of a RNP). SLiMs of this group have higher Shannon
diversity indices than those from the other groups for all four
RNPs (Figure 1B, 1D, 1F and 1H). In contrast, most of SLiMs
belong to the third group, which occur in less than 10% of the
RNP. These results indicate that most SLiMs might be created
sporadically by mutations and might be present in specific IAV
strains. Together, the combination of occurrences and the
Shannon diversity index can be used to distinguish different types
of diversity of the SLiM composition. As shown in Figure 1, the
first group of SLiMs has low Shannon diversity index value and
high occurrence (greater than 90%), which represents highly
conserved motifs (common for all IAVs). The second group of
SLiM has high Shannon diversity index value and occurrence of
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the number of SLiMs in this group is few (Table 1). In contrast, the
third group of SLiM has both low Shannon diversity index value
and low occurrence (less than 10%). The number of SLiMs in this
group is plenty (Figure 1 and Table 1). The average numbers of
SLiMs per gene (numbers in the brackets beside the raw frequency
in Table 1) indicate the second and third SLiM groups represent
different types of SLiM composition diversity.
Comparison of PA protein SLiM compositions among
IAVs from different hosts. To gain a deeper understanding of
the SLiM composition of IAV RNPs, the SLiM compositions of
IAV RNPs from different hosts were compared. Using the PA
protein as an example, the comparison of the SLiM composition of
PA proteins among IAVs from avian (A_PA), human (H_PA) and
mammalian (M_PA) hosts reveals that the 791 identified SLiMs
can be classified into three groups (Information S5). The first
group is composed of 80 highly conserved SLiMs (with an
occurrence of greater than 90% in all PA protein sequences) that
are common in all PA proteins regardless of the IAV host range
(Information S6). The 80 SLiMs may be basic motifs that are
essential for normal PA protein functions. The second group
includes 24 partially conserved SLiMs (with an occurrence
between 90–10% for all PA protein sequences). The third group
contains 687 low occurrence SLiMs (with an occurrence of less
than 10% in all PA protein sequences). 21 locations that contain
two or more overlapping SLiMs from the first group were found
(red rectangles in Information S6). Locations with highly
conserved overlapping SLiMs may represent short protein
domains that can respond to multiple host factors/pathways (see
discussion).
To uncover IAV host specific motifs in PA proteins in the
second group, the test for difference among k proportions was
performed. Because of the large sample size used in this study, a p
value of 10
2100 was used as the cut-off value. In total, 14 SLiMs
that have a p value of less than 10
2100 and have an occurrence of
greater than 80% in the PA protein sequences from avian, human
or mammalian IAVs were identified. Moreover, the log-likelihood
ratio tests were performed to test the dependence between the
existence of a SLiM and the host origin of the PA protein. All 14
SLiMs have a p value of less than 0.05 indicate there are
dependences between the existence of the 14 SLiMs and the host
origin of PA proteins. As shown in Figure 2A, all 14 SLiMs have a
lower occurrence in PA proteins from human IAVs than in PA
proteins from avian and mammalian IAVs. Notably, three of the
SLiMs (LIG_SPAK-OSR1_1_204, MOD_PIKK_1_274 and
MOD_GSK3_1_402) occur rarely in PA proteins from human
IAVs. It is known that the PA sequences are not completely
independent because there are phylogenetic relationships between
them. A SLiM may be derived either from sequences of the same
lineage (founder effect) or from host adaptation (convergent
evolution). To reveal the underlying phylogenetic relationship, all
PA sequences from each host class were used to perform pairwise
alignments and the identities of all sequence pairs were computed
(Figure 2B). Moreover, all sequences harbor a SLiM from each
host class were used to perform pairwise alignments and the
identities of all sequence pairs were computed. Two of the 14
SLiMs are shown in Figure 2C and 2D as examples. If two PA
protein sequences with an identity greater than 95% are
considered as sequences from the same lineage, then a SLiM
identified from PA protein sequences with an identity greater than
95% may represent a result of founder effect. In contrast, a SLiM
identified from PA protein sequences with an identity less than
95% may represent an event of host adaptation (convergent
evolution). Results in Figure 2C and 2D suggest both of the
founder effect and host adaptation were occurred. Similar
phenomena were found for other SLiMs (Information S7).
Comparison of the SLiM compositions of PA protein from
IAVs with different virulence
To uncover potential IAV virulence-associated motifs in PA
proteins, a comparison of PA SLiM compositions from all IAVs
and HP IAVs was conducted. The 152 SLiMs identified can be
classified into three groups (Information S8). The first group is
composed of 80 highly conserved SLiMs (with an occurrence of
greater than 90% in all PA protein sequences) that are common in
all PA proteins regardless of IAV virulence. The second group
includes 24 partially conserved SLiMs (with an occurrence
between 90–10% in all PA protein sequences). The third group
has 48 low occurrence SLiMs (with an occurrence of less than 10%
in all PA protein sequences). Therefore, the number of candidate
motifs in the third group was reduced from 687 to 48. If a SLiM
appears in PA proteins from HP IAVs but is very rare in PA
proteins from human IAVs, it may be associated with the virulence
of HP IAVs through its effect on the function of the PA protein.
Using two criteria, a very low occurrence (less than 10%) in
human IAV PA proteins and its presence in HP IAV PA proteins,
47 SLiMs from the second (24 motifs) and third (48 motifs) groups
were identified. Moreover, a SLiM from the second group that has
a high occurrence in PA proteins from both avian and mammalian
IAVs but a low occurrence (19.5%) in PA proteins from human
IAVs was found. The 48 SLiMs (Information S9) are candidate
sites that might affect PA protein activity and might be associated
with IAV transcription and/or replication efficiency. 10 of the 48
SLiMs are even more notable. 3 of the 10 SLiMs (LIG_14-3-
3_3_57, MOD_PIKK_1_650 and MOD_CK2_1_650) are likely
avian IAV specific (labelled ‘‘A’’ in Information S9). 4 of the 10
SLiMs (MOD_CK2_1_17, LIG_FHA_2_18 and MOD_CK2_
1_686) are likely mammalian IAV specific (labelled ‘‘M’’ in
Information S9). Another 3 of the 10 SLiMs (LIG_SPAK-
OSR1_1_204, MOD_PIKK_1_274 and MOD_GSK3_1_402)
have a high occurrence in PA proteins from avian and mammalian
IAVs (labelled ‘‘A & M’’ in Information S9).
Comparison of the SLiM compositions of PB1 proteins
among IAVs from different hosts
A comparison of PB1 SLiM compositions among IAVs from
avian (A_PB1), human (H_PB1) and mammalian (M_PB1) hosts
reveals that the 783 identified SLiMs can be classified into three
groups (Information S10). The first class is composed of 81 highly
conserved SLiMs (with an occurrence of greater than 90% in all
PB1 protein sequences) that are common in all PB1 proteins
regardless of the IAV host range (Information S11). These 81
SLiMs may be basic motifs that are essential for normal PB1
protein functions. The second class includes 13 partially conserved
SLiMs (with an occurrence between 90–10% in all PB1 protein
sequences). The third class has 689 low occurrence SLiMs (with an
occurrence of less than 10% in all PB1 protein sequences). 17
locations that contain two or more overlapping SLiMs from the
first group were identified (red rectangles in Information S11).
To uncover IAV host specific motifs in PB1 proteins in the
second group, the test for difference among k proportions is
performed. Using the p value of 10
2100 as a cut off value, 9 SLiMs
were identified that have an occurrence of greater than 80% in the
PB1 protein sequences from avian, human or mammalian IAVs.
Moreover, the log-likelihood ratio tests were performed to test the
dependence between the existence of a SLiM and the host origin
of the PB1 protein. All 9 SLiMs have a p value of less than 0.05
A Comparative Study of IAV RNP SLiM Compositions
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38637Figure 1. The distribution of occurrence and the Shannon diversity index of SLiMs in IAV RNPs. For A, C, E and G the Y-axis indicates the
number of identified SLiMs, and the X-axis indicates the occurrence of the SLiMs. For B, D, F and H the Y-axis indicates the Shannon diversity index.
The X-axis indicates the occurrences of SLiMs. The occurrence of a SLiM at an aa position is computed by the number of the RNP sequences with the
SLiM at the same position divided by total number of the RNP sequences. (A) The frequency distribution of the identified SLiMs in the PA protein
sequences. (B) The Shannon diversity index distribution of the identified SLiMs in the PA protein sequences. (C) The frequency distribution of the
identified SLiMs in the PB1 protein sequences. (D) The Shannon diversity index distribution of the identified SLiMs in the PB1 protein sequences. (E)
The frequency distribution of the identified SLiMs in the PB2 protein sequences. (F) The Shannon diversity index distribution of the identified SLiMsi n
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SLiMs and the host origin of PB1 proteins. As shown in Figure 3A,
8 of the 9 SLiMs have a lower occurrence in PB1 proteins from
human IAVs than PB1 proteins from avian and mammalian IAVs.
Notably, two of them (LIG_MAPK_1_584 and MOD_-
PAK_2_429) have a very low occurrence in PB1 proteins from
human IAVs. In contrast, The SLiM MOD_PIKK_1_580 is
specific to the PB1 proteins from human and mammalian IAVs.
To reveal the underlying phylogenetic relationship, all PB1
sequences from each host class were used to perform pairwise
alignments and the identities of all sequence pairs were computed
(Figure 3B). Moreover, all sequences harbor a SLiM from each
host class were used to perform pairwise alignments and the
identities of all sequence pairs were computed. Two of the 9
SLiMs are shown in Figure 3C and 3D as examples. If two PB1
protein sequences with an identity greater than 95% are
considered as sequences from the same lineage, then a SLiM
identified from PB1 protein sequences with an identity greater
than 95% may represent a result of founder effect. In contrast, a
SLiM identified from PB1 protein sequences with an identity less
than 95% may represent an event of host adaptation (convergent
evolution). Results in Figure 3C and 3D suggest both of the
founder effect and host adaptation were occurred. Similar
phenomena were found for other SLiMs (Information S12).
Comparison of the SLiM composition of the PB1 protein
from IAVs of different levels of virulence
To uncover potential IAV virulence-associated motifs in PB1
proteins, a comparison of PB1 SLiM compositions from all IAVs
and HP IAVs was conducted. The 126 SLiMs identified can be
classified into three groups (Information S13). The first group is
composed of 81 highly conserved SLiMs (with an occurrence of
greater than 90% in all PB1 protein sequences) that are common
in all PB1 proteins regardless of IAV virulence. The second group
includes 12 partially conserved SLiMs (with an occurrence
between 90–10% in all PB1 protein sequences). The third group
has 33 low occurrence SLiMs (with an occurrence of less than 10%
of all PB1 protein sequences). Therefore, the number of candidate
motifs in the third group was reduced from 689 to 33. If a SLiM
appears in PB1 proteins from HP IAVs but is very rare in PB1
proteins from human IAVs, it may be associated with the virulence
of HP IAVs through its effect on the function of the PB1 protein.
Using two criteria, a very low occurrence (less than 10%) in
human IAV PB1 proteins and the presence in HP IAV PB1
proteins, 33 SLiMs from the second and third groups were
identified. Moreover, two SLiMs from the second group were
found that have a high occurrence in PB1 proteins from avian and
mammalian IAVs but a low occurrence (approximately 20%) in
PB1 proteins from human IAVs. The 35 SLiMs (Information S14)
are candidate sites that might affect PB1 protein activity and might
be associated with IAV transcription and/or replication efficiency.
Notably, 2 of the 35 SLiMs (MOD_PAK_2_429 and LIG_-
MAPK_1_584) are both avian and/or mammalian IAV specific
(labelled ‘‘A & M’’ in Information S14).
Comparison of the SLiM compositions of PB2 proteins
among IAVs from different hosts
A comparison of PB2 SLiM compositions among IAVs from
avian (A_PB2), human (H_PB2) and mammalian (M_PB2) hosts
reveals that the 712 identified SLiMs can be classified into three
groups (Information S15). The first class is composed of 94 highly
conserved SLiMs (with an occurrence of greater than 90% of all
PB2 protein sequences) that are common in all PB2 proteins
regardless of the IAV host range (Information S16). The 94 SLiMs
may be basic motifs that are essential for normal PB2 protein
functions. The second class includes 25 partially conserved SLiMs
(with an occurrence between 90–10% of all PB2 protein
sequences). The third class has 593 low occurrence SLiMs (with
an occurrence of less than 10% of all PB2 protein sequences). In
total, 23 locations that contain two or more overlapping SLiMs
from the first group were found (red rectangles in Information
S16).
To uncover IAV host specific motifs in PB2 proteins in the
second group, the test for difference among k proportions is
performed. Using the p value of 10
2100 as a cut-off value, 9 SLiMs
that have an occurrence of greater than 80% in PB2 protein
sequences from avian, human or mammalian IAVs were
identified. Moreover, the log-likelihood ratio tests were performed
to test the dependence between the existence of a SLiM and the
host origin of the PB2 protein. All 9 SLiMs have a p value of less
than 0.05 indicate there are dependences between the existence of
the 9 SLiMs and the host origin of PB2 proteins. As shown in
Figure 4A, 7 of the 9 SLiMs have lower occurrence in the PB2
proteins from human IAVs than the PB2 proteins from avian and
mammalian IAVs. Notably, 3 of the 9 SLiMs (LIG_14-3-3_2_555,
MOD_PAK_1_268 and MOD_PAK_2_268) have a very low
occurrence in PB2 proteins from human IAVs. In contrast, 2
SLiMs (MOD_CK2_1_681 and MOD_GSK3_1_681) are specific
to PB2 proteins from human and mammalian IAVs. To reveal the
underlying phylogenetic relationship, all PB2 sequences from each
host class were used to perform pairwise alignments and the
identities of all sequence pairs were computed (Figure 4B).
Moreover, all sequences harbor a SLiM from each host class
were used to perform pairwise alignments and the identities of all
sequence pairs were computed. Two of the 9 SLiMs are shown in
Figure 4C and 4D as examples. If two PB2 protein sequences with
an identity greater than 95% are considered as sequences from the
same lineage, then a SLiM identified from PB2 protein sequences
with an identity greater than 95% may represent a result of
founder effect. In contrast, a SLiM identified from PB2 protein
the PB2 protein sequences. (G) The frequency distribution of the identified SLiMs in the NP protein sequences. (H) The Shannon diversity index
distribution of the identified SLiMs in the NP protein sequences.
doi:10.1371/journal.pone.0038637.g001
Table 1. A Comparison of the SLiM distributions of RNPs from
highly virulent/pandemic (Pan) IAVs and RNPs from all IAVs.
Numbers in the brackets beside the raw frequency are
average numbers of SLiMs per gene.
Occurrence 1,0.9 0.9,0.1 0.1,0
All PA 80 (79.3) 24 (12.3) 687 (1.2)
Pan_PA 80 (79.0) 24 (13.6) 48 (3.3)
All PB1 80 (79.3) 14 (8.0) 689 (0.9)
Pan_PB1 80 (79.0) 13 (8.8) 33 (0.7)
All PB2 94 (93.3) 25 (9.7) 593 (1.2)
Pan_PB2 94 (92.5) 23 (9.6) 40 (2.2)
All NP 37 (36.1) 28 (12.5) 565 (0.7)
Pan_NP 37 (36.9) 25 (11.0) 21 (0.2)
doi:10.1371/journal.pone.0038637.t001
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of host adaptation (convergent evolution). Results in Figure 4C
and 4D suggest both of the founder effect and host adaptation
were occurred. Similar phenomena were found for other SLiMs
(Information S17).
Comparison of the SLiM composition of PB2 proteins
from IAVs with different levels of virulence
To uncover potential IAV virulence-associated motifs in PB2
proteins, a comparison of PB2 SLiM compositions from all IAVs
and HP IAVs was conducted. The 157 SLiMs identified can be
classified into three groups (Information S18). The first group is
composed of 94 highly conserved SLiMs (with an occurrence of
greater than 90% in all PB2 protein sequences) that are common
in all PB2 proteins regardless of IAV virulence. The second group
includes 23 partially conserved SLiMs (with an occurrence
between 90–10% in all PB2 protein sequences). The third group
has 40 low occurrence SLiMs (with an occurrence less than 10% in
all PB2 protein sequences). Therefore, the number of candidate
motifs in the third group was reduced from 593 to 40. If a SLiM
appears in the PB1 proteins from HP IAVs but is very rare in PB2
proteins from human IAVs, it may be associated with the virulence
of HP IAVs through its effect on the function of the PB2 protein.
Using two criteria, a very low occurrence (less than 10%) in
human IAV PB2 proteins and the presence in HP IAV PB2
proteins, 41 SLiMs from the second and third groups were
identified. Moreover, a SLiM from the second group was found
that has a high occurrence in PB2 proteins from avian and
mammalian IAVs but a low occurrence (25.4%) in PB2 proteins
from human IAVs. The 42 SLiMs (Information S19) are
candidates sites that might affect PB2 protein activity and might
be associated with IAV transcription and/or replication efficiency.
Importantly, 14 of the 42 SLiMs are even more notable. Three of
them (MOD_CK2_1_336, LIG_FHA_2_337 and LIG-
TRAF2_1_339) are avian IAV specific (labelled ‘‘A’’ in Informa-
tion S19). Another eight SLiMs (LIG_SH3_3_536, TRG_LysEn-
d_APsAcLL_1_441, MOD_PKA_2_659, LIG_APCC_KENbox_
2_698, MOD_CK2_1_714, LIG_FHA_2_715, TRG_NLS_
MonoCore_2_735 and TRG_NLS_MonoExtN_4_736) are mam-
malian IAV specific (labelled ‘‘M’’ in Information S19). Three
Figure 2. SLiMs from IAV PA proteins that have a differential occurrence in IAVs from different hosts. (A) 14 SLiMs that have a
differential occurrence in IAV PA proteins from different hosts. A_PA, H_PA and M_PA indicate the PA proteins from avian, human and IAV,
respectively. The Y-axis indicates the occurrence of each identified SLiM. The X-axis indicates the name and position of each identified SLiM in the PA
proteins. For example, ‘‘LIG_14-3-3_3’’ in ‘‘LIG_14-3-3_3_615’’ is the name of the SLiM, and 615 is the amino acid position where the SLiM starts. (B)
The distribution of pairwise alignment identity of all PA protein sequences from avian, human and mammalian IAVs. (C) The distribution of pairwise
alignment identity of PA protein sequences which harbor the SLiM LIG_PTB_Apo_2_328 from avian, human and mammalian IAVs. (D) The distribution
of pairwise alignment identity of PA protein sequences which harbor the SLiM LIG_SPAK-OSR1_1_204 from avian, human and mammalian IAVs. For B,
C and D, the X-axis indicates the number of pairwise alignments of IAV PA protein sequences. The Y-axis indicates the identity of pairwise alignment
(the percentage of identical amino acids that are the same in both PA sequences). Blue: PA protein sequences from avian IAVs. Red: PA protein
sequences from human IAVs. Green: PA protein sequences from mammalian IAVs.
doi:10.1371/journal.pone.0038637.g002
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3_2_555) are avian and mammalian IAV specific (labelled ‘‘A &
M’’ in Information S19).
Comparison of the SLiM composition of NP proteins
among IAVs from different hosts
A comparison of NP SLiM compositions among IAVs from
avian (A_NP), human (H_NP) and mammalian (M_NP) hosts
reveals that the 630 identified SLiMs can be classified into three
groups (Information S20). The first class is composed of 37 highly
conserved SLiMs (with an occurrence of greater than 90% in all
NP protein sequences) that are common in all NP proteins
regardless of IAV host range (Information S21). The 37 SLiMs
may be basic motifs that are essential for normal NP protein
functions. The second class includes 28 partially conserved SLiMs
(with an occurrence between 90–10% in all NP protein sequences).
The third class has 565 low occurrence SLiMs (with an occurrence
of less than 10% in all NP protein sequences). 6 locations that
contain two or more overlapping SLiMs from the first group were
found (red rectangles in Information S21).
To uncover IAV host specific motifs in NP proteins in the
second group, the test for differences among k proportions is
performed. Using the p value of 10
2100 as a cut-off value, 13
SLiMs that have an occurrence of greater than 80% in the NP
protein sequences from avian, human or mammalian IAVs were
identified. Moreover, the log-likelihood ratio tests were performed
to test the dependence between the existence of a SLiM and the
host origin of the NP protein. All 13 SLiMs have a p value of less
than 0.05 indicate there are dependences between the existence of
the 13 SLiMs and the host origin of NP proteins. As shown in
Figure 5A, 10 of the 13 SLiMs have a lower occurrence in the NP
proteins from human IAVs than in the NP proteins from avian
and mammalian IAVs. Notably, 2 of them
(LIG_BRCT_BRCA1_1_309 and LIG_MAPK_1_98) have a
very low occurrence in NP proteins from human IAVs. In
contrast, 2 SLiMs (MOD_SUMO_451 and TRG_ENDOCY-
Figure 3. SLiMs from IAV PB1 proteins that have a differential occurrence in IAVs from different hosts. (A) 9 SLiMs that have a
differential occurrence in IAV PB1 proteins from different hosts. A_PB1, H_PB1 and M_PB1 indicate the PB1 proteins from avian, human and IAV,
respectively. The Y-axis indicates the occurrence of each identified SLiM. The X-axis indicates the name and position of each identified SLiM in the PB1
proteins. For example, ‘‘LIG_FHA_2’’ in ‘‘LIG_FHA_2_55’’ is the name of the SLiM, and 55 is the amino acid position where the SLiM starts. (B) The
distribution of pairwise alignment identity of all PB1 protein sequences from avian, human and mammalian IAVs. (C) The distribution of pairwise
alignment identity of PB1 protein sequences which harbor the SLiM LIG_FHA_2_55 from avian, human and mammalian IAVs. (D) The distribution of
pairwise alignment identity of PB1 protein sequences which harbor the SLiM MOD_PKA_2_429 from avian, human and mammalian IAVs. For B, C and
D, the X-axis indicates the number of pairwise alignments of IAV PB1 protein sequences. The Y-axis indicates the identity of pairwise alignment (the
percentage of identical amino acids that are the same in both PB1 sequences). Blue: PB1 protein sequences from avian IAVs. Red: PB1 protein
sequences from human IAVs. Green: PB1 protein sequences from mammalian IAVs.
doi:10.1371/journal.pone.0038637.g003
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mammalian IAVs. To reveal the underlying phylogenetic
relationship, all NP sequences from each host class were used to
perform pairwise alignments and the identities of all sequence
pairs were computed (Figure 5B). Moreover, all sequences harbor
a SLiM from each host class were used to perform pairwise
alignments and the identities of all sequence pairs were computed.
Two of the 13 SLiMs are shown in Figure 5C and 5D as examples.
If two NP protein sequences with an identity greater than 95% are
considered as sequences from the same lineage, then a SLiM
identified from NP protein sequences with an identity greater than
95% may represent a result of founder effect. In contrast, a SLiM
identified from NP protein sequences with an identity less than
95% may represent an event of host adaptation (convergent
evolution). Results in Figure 5C and 5D suggest both of the
founder effect and host adaptation were occurred. Similar
phenomena were found for other SLiMs (Information S22).
Comparison of the SLiM composition of NP proteins from
IAVs with different virulence
To uncover potential IAV virulence associated motifs in NP
proteins, a comparison of NP SLiM compositions from all IAVs
and HP IAVs was conducted. The 83 SLiMs identified can be
classified into three groups (Information S23). The first group is
composed of 37 highly conserved SLiMs (with an occurrence of
greater than 90% in all NP protein sequences) that are common in
all NP proteins regardless of IAV virulence. The second group
includes 25 partially conserved SLiMs (with an occurrence
between 90–10% in all NP protein sequences). The third group
has 21 low occurrence SLiMs (with an occurrence of less than 10%
in all NP protein sequences). Therefore, the number of candidate
motifs in the third group was reduced from 565 to 21. If a SLiM
appears in NP proteins from HP IAVs but is very rare in NP
proteins from human IAVs, it may be associated with the virulence
of the HP IAVs through its effect on the function of the NP
protein. Using two criteria, a very low occurrence (less than 10%)
Figure 4. SLiMs from IAV PB2 proteins that have a differential occurrence in IAVs from different hosts. (A) 9 SLiMs that have a
differential occurrence in IAV PB2 proteins from different hosts. A_PB2, H_PB2 and M_PB2 indicate the PB2 proteins from avian, human and IAV,
respectively. The Y-axis indicates the occurrence of each identified SLiM. The X-axis indicates the name and position of each identified SLiM in the PB1
proteins. For example, ‘‘LIG_SH3_3’’ in ‘‘LIG_SH3_3_106’’ is the name of the SLiM, and 106 is the amino acid position where the SLiM starts. (B) The
distribution of pairwise alignment identity of all PB2 protein sequences from avian, human and mammalian IAVs. (C) The distribution of pairwise
alignment identity of PB2 protein sequences which harbor the SLiM LIG_SH3_3_106 from avian, human and mammalian IAVs. (D) The distribution of
pairwise alignment identity of PB2 protein sequences which harbor the SLiM MOD_GSK3_1_681 from avian, human and mammalian IAVs. For B, C
and D, the X-axis indicates the number of pairwise alignments of IAV PB2 protein sequences. The Y-axis indicates the identity of pairwise alignment
(the percentage of identical amino acids that are the same in both PB2 sequences). Blue: PB2 protein sequences from avian IAVs. Red: PB2 protein
sequences from human IAVs. Green: PB2 protein sequences from mammalian IAVs.
doi:10.1371/journal.pone.0038637.g004
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proteins, 24 SLiMs from the second and third groups were
identified. The 24 SLiMs (Information S24) are candidate sites
that might affect NP protein activity and might be associated with
IAV transcription and/or replication efficiency. In total, 6 of the
24 SLiMs are even more notable. 3 of them (LIG_APCC_KEN-
box_2_318, LIG_14-3-3_3_470 and MOD_ProDKin_1_470) are
specific to the NP proteins from mammalian IAV (labelled ‘‘M’’ in
Information S24). Another 3 SLiMs (LIG_MAPK_1_98,
LIG_BRCT_BRCA1_1_309 and MOD_GSK3_1_370) are spe-
cific to the NP proteins from avian and mammalian IAV (labelled
‘‘A & M’’ in Information S24).
SLiMs at the vicinity of amino acids that were associated
with host adaptation of IAV PA proteins
Several amino acid sites (AASs) in IAV RNPs were reported to
affect IAV RNP activity or were associated with IAV host
adaptation [15–31]. In total, 99 AASs (25 in the PA protein, 16 in
the PB1 protein, 31 in the PB2 protein and 27 in the NP protein)
from these reports were mapped to 185 SLiMs (42 in the PA
protein, 35 in the PB1 protein, 67 in the PB2 protein and 41 in the
NP protein) identified in this study (Table 2–5). For instance,
Gabriel et al used the highly pathogenic avian IAV SC35 to
demonstrate that 7 AASs in IAV RNPs are associated with host
adaptation [22]. All 7 of the AASs have corresponding SLiMs
identified in this study. The AAS 615 of the PA protein can be
mapped to LIG_FHA_2_612, LIG_14-3-3_3_615 and LIG_14-3-
3_1_615 of the PA protein (Table 2). The AAS 13 of the PB1
protein can be mapped to MOD_PIKK_1_11 and
MOD_GSK3_1_13 of the PB1 protein (Table 3). The AAS 678
of the PB1 protein can be mapped to MOD_PIKK_1_675 of the
PB1 protein (Table 3). The AAS 333 of the PB2 protein can be
mapped to MOD_PKA_1_331, MOD_PKA_2_331, MOD_
CK2_1_335, MOD_CK2_1_336 and LIG_FHA_2_336 of the
PB2 protein (Table 4). The AAS 701 of the PB2 protein can be
mapped to LIG_MAPK_1_702 of the PB2 protein (Table 4). The
AAS 714 of the PB2 protein can be mapped to
MOD_CK2_1_714, LIG_FHA_2_715 and MOD_SUMO_717
Figure 5. SLiMs from IAV NP proteins that have a differential occurrence in IAVs from different hosts. (A) 13 SLiMs that have a
differential occurrence in IAV NP proteins from different hosts. A_NP, H_NP and M_NP indicate the NP proteins from avian, human and IAV,
respectively. The Y-axis indicates the occurrence of each identified SLiM. The X-axis indicates the name and position of each identified SLiM in the NP
proteins. For example, ‘‘MOD_SUMO’’ in ‘‘MOD_SUMO_451’’ is the name of the SLiM, and 451 is the amino acid position where the SLiM starts. (B) The
distribution of pairwise alignment identity of all NP protein sequences from avian, human and mammalian IAVs. (C) The distribution of pairwise
alignment identity of NP protein sequences which harbor the SLiM LIG_BRCT_BRCA1_1_309 from avian, human and mammalian IAVs. (D) The
distribution of pairwise alignment identity of NP protein sequences which harbor the SLiM MOD_SUMO_451 from avian, human and mammalian
IAVs. For B, C and D, the X-axis indicates the number of pairwise alignments of IAV NP protein sequences. The Y-axis indicates the identity of pairwise
alignment (the percentage of identical amino acids that are the same in both NP sequences). Blue: NP protein sequences from avian IAVs. Red: NP
protein sequences from human IAVs. Green: NP protein sequences from mammalian IAVs.
doi:10.1371/journal.pone.0038637.g005
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be mapped to LIG_APCC_KENbox_2_318 and MOD_
GSK3_1_319 of the NP protein (Table 5). Altogether, SLiMs
identified in this study provide possible molecular mechanisms that
may explain the activity, interaction or localization changes of
IAV RNPs caused by those AAS changes.
Proposed cellular processes RNPs may be involved
through SLiMs identified
The compositions of SLiMs in RNPs provide information
regarding the pathways that the RNPs may be involved in. As
shown in Table 6, RNPs with SH2 and SH3 ligand motifs,
LIG_MAPK_1, LIG_14-3-3, LIG_FHA_2 and protein kinase
phosphorylation sites may be involved in the MAPK, Wnt and
Table 2. SLiMs mapped to the vicinity of amino acids that were reported as genetic signatures or are associated with the
adaptation of IAV PA proteins to the host.
SLiMs identified in this study Start End SLiM sequences Amino acid References
LIG_FHA_2_18 18 24 IVELAEKTMKEYGEDLK 20, 22 [23,27]
MOD_SUMO_28 28 31 EYGEDPKIETNKFA 28 [19,20,25]
LIG_14-3-3_3_57 57 62 HFIDERSESIIVESGD 55, 57 [19,20,25]
LIG_14-3-3_2_57 57 63 HFIDERGESTIVESGDP 55, 57 [19,20,25]
MOD_GSK3_1_58 58 65 FIDERGESTIVESGDPNA 55, 57 [19,20,25]
MOD_GSK3_1_62 62 69 RGESIIVESGDPTALLKH 65, 66 [25,26]
LIG_SH3_3_62 62 68 QGESIIVEPEDPNALLK 65, 66 [25,26]
TRG_NES_CRM1_1_67 67 80 IVESGDLNALLKHRFEIIEGRDRT 65, 66 [25,26]
LIG_NRBOX_67 67 73 IVESGDLNALLKHRFEI 65, 66 [25,26]
MOD_GSK3_1_82 82 89 EIIEGRDRTMAWTVVNSI 85 [18]
LIG_PP1_82 82 89 EIIEGRDRTIAWTVINSI 85 [18]
LIG_FHA_2_96 96 102 VNSICNTTGVEKPKFLP 97, 100 [19,20,25,27,28]
LIG_SH3_3_97 97 103 NSICNTTGVEKPKFLPD 97, 100 [19,20,25,27,28]
LIG_FHA_2_121 121 127 RFIEIGVTRREVHIYYL 127 [15]
LIG_SH2_STAT5_131 131 134 EVHIYYLEKANKIK 133 [17]
MOD_GSK3_1_133 133 140 HIYYLEKATKIKSENTHI 133 [17]
MOD_GSK3_1_187 187 194 MASRGLWDSFRQSERGEE 186 [18]
LIG_SPAK-OSR1_1_204 204 208 ETIEERFEITGTMRK 204 [19]
MOD_CK2_1_221 221 227 DQSLPPNFSSLENFRAY 225 [19,20,25]
LIG_CYCLIN_1_266 266 270 LKTTPRPLRLPNGPP 268 [19,20,25]
LIG_14-3-3_1_266 266 271 LKTTPRPLTLPDGPPC 268 [19,20,25]
LIG_FHA_2_267 267 273 KTTPRPLTLPDGPPCSQ 268 [19,20,25]
LIG_SH3_3_268 268 274 TTPRPLRLPEGPPCSQR 268 [19,20,25]
MOD_PIKK_1_274 274 280 RLPNGPPCSQRSKFLLM 277 [23]
LIG_WW_1_274 274 277 KLPNGPPCYQRSKF 277 [23]
LIG_SH3_3_319 319 325 FFGWKEPTVVKPHEKGI 321 [25]
LIG_SH2_STAT5_321 321 324 GWKEPYIVKPHEKG 321 [25]
LIG_SH2_STAT5_334 334 337 GINPNYLLAWKQVL 336 [15,18]
LIG_CYCLIN_1_339 339 342 YLLSWKQLLAELQD 337 [20,25]
LIG_Actin_WH2_2_353 353 369 FEDEKKIPRVKNMKKTSPLKWALGENM 355, 356 [19,23]
MOD_GSK3_1_356 356 363 EEKIPRTKTMKKTSQLKW 355, 356 [19,23,25,29]
LIG_MAPK_1_358 358 366 KIPKTKNMKKTIQLKWALG 355, 356 [19,23,25,29]
MOD_PKA_2_384 384 390 VDFDDCRDTSDLKQYDS 382 [25]
LIG_CYCLIN_1_401 401 405 DEPEPRSLAIWVQNE 400, 404 [19,20,25]
MOD_GSK3_1_402 402 409 EPELRSLASWIQSEFNKA 400, 404, 409 [19,20,25]
MOD_CK2_1_418 418 424 KACELTDSSWIELDEIG 421 [25]
LIG_FHA_2_419 419 425 ACELTDSTWIELDEIGE 421 [25]
LIG_SH3_3_554 554 560 LLRTAVGQVSRPMFLYV 552, 556 [17,19,20,25,29]
LIG_FHA_2_612 612 618 MTKEFFETKSETWPIGE 615 [15,22]
LIG_14-3-3_3_615 615 620 EFFETKSETWPIGESP 615 [15,22]
LIG_14-3-3_1_615 615 620 EFFENRSETWPIGESP 615 [15,22]
doi:10.1371/journal.pone.0038637.t002
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LIG_TRAF2_1, LIG_TRAF6, LIG_SH2_STAT3 and
LIG_SH2_STAT5 may be involved in the TNF/cytokine
signaling pathway [3]. Moreover, RNPs with TRG_LysEnd_AP-
sAcLL_1, TRG_ENDOCYTIC_2, LIG_EH1_1 and LIG_Ac-
tin_WH2_2 may interact with actin and be involved in
intracellular trafficking pathways [3]. All of these host cellular
processes and pathways have been reported to be involved in post-
entry steps of IAV replication [32,33]. The different compositions
of SLiMs among RNPs reflect the functional diversity of RNPs.
Each RNP with a different SLiM composition has a varying ability
to interact with different cellular processes and signal transduction
pathways, and results in different impacts on viral replication and
host adaptation.
Discussion
In total, 292 highly conserved SLiMs were found in IAV RNPs
regardless of IAV host range. These SLiMs may be basic motifs
that are essential for the normal function of RNPs. Two of them
have been experimentally identified in IAV RNP proteins. The
first SLiM is the nuclear localization signal (NLS) located between
amino acid 182–217 in the IAV PB1 proteins [34]. Several NLS
associated SLiMs were identified in this study as shown in
Information S11. The second SLiM is the nuclear localization
signal (NLS) located in the C-terminal of the IAV PB2 proteins
[35]. The NLS associated SLiM was identified in this study as
shown in Information 16. These examples suggest that computa-
Table 3. SLiMs mapped to the vicinity of amino acids that were reported as genetic signatures or are associated with the
adaptation of IAV PB1 proteins to the host.
SLiMs identified in this study Start End SLiM sequences Amino acid References
MOD_PIKK_1_11 11 17 TLLFLKVPTQNAISTTF 13 [22,27]
MOD_GSK3_1_13 13 20 LFLKVPAQSAISTTFPYT 13 [22]
LIG_14-3-3_2_52 52 58 HQYSERGKWTINTETGA 52 [29]
MOD_PKA_2_53 53 59 QYSERGRWTTNTETGAP 52 [29]
MOD_CK2_1_54 54 60 YSEKGKWTTNTETGAPQ 52 [29]
MOD_GSK3_1_54 54 61 YSEKGKWTTNTETGAPQL 52 [29]
MOD_CK2_1_103 103 109 SHPGIFENSCLETMEVV 103 [23]
MOD_GSK3_1_103 103 110 SHPGIFENSCIETMEVVQ 103 [23]
TRG_LysEnd_APsAcLL_1_214 214 219 KQKLNRKGYLIRALTL 216 [19]
LIG_SH2_STAT5_217 217 220 VNKRGYLIRALTLN 216 [19]
MOD_PIKK_1_290 290 296 VVRKMMTNSQDTELSFT 292 [23]
LIG_APCC_Dbox_1_315 315 323 NENQNPRMFLAMITYITKN 317 [15]
LIG_14-3-3_2_316 316 322 ENQNPRVFLTMITYITK 317 [15]
LIG_SH2_STAT5_324 324 327 LAMITYITRNQPEW 327 [19]
MOD_PIKK_1_325 325 331 AMITYITRSQPEWFRNV 327 [19]
MOD_CK2_1_325 325 331 AMITYITRSQPEWFRNV 327 [19]
LIG_14-3-3_2_334 334 340 QPEWFRNILSIAPIMFS 336 [19,25]
LIG_FHA_2_372 372 378 QIPAEMLTSIDLKYFNE 372 [23]
LIG_SH2_GRB2_380 380 383 SIDLKYFNESTRKK 384 [15]
LIG_SH2_STAT5_380 380 383 SIDLKYFNESTRKK 384 [15]
MOD_CK2_1_384 384 390 KYFNESTRTKIEKIRPL 384 [15]
LIG_FHA_2_385 385 391 YFNESTRTKIEKIRPLL 384 [15]
LIG_MAPK_1_386 386 397 FNESTRKKIEKIRPLLIDGTAS 384 [15]
MOD_GSK3_1_517 517 524 FGVSGINESADMSIGVTV 517 [29]
LIG_PTB_Apo_2_551 551 558 MALQLFIKNYRYTYRCHR 552 [15]
LIG_PTB_Phospho_1_551 551 557 MALQLFIKNYRYTYRCH 552 [15]
MOD_PKA_2_555 555 561 LFIKDYRYTYRCHRGDT 552 [15]
MOD_CK2_1_575 575 581 TRRSFELKTLWEQTRSK 578 [26]
LIG_FHA_2_576 576 582 RRSFELKTLWDQTQSKA 578 [26]
MOD_PIKK_1_580 580 586 ELKKLWDQTQSKAGLLV 584 [29]
MOD_GSK3_1_580 580 587 ELKKLWDQTQSRTGLLVS 584 [29]
LIG_MAPK_1_584 584 591 LWEQTRSKAGLLVSDGGP 584 [29]
MOD_SUMO_611 611 614 IPEVCLKWELMDED 614 [26]
LIG_Clathr_ClatBox_1_615 615 619 CLKWELMDVDYQGRL 614 [26]
MOD_PIKK_1_675 675 681 RNRSILNTSQRGILEDE 677, 678 [16,22]
doi:10.1371/journal.pone.0038637.t003
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SLiMs identified in this study Start End SLiM sequences Amino acid References
LIG_CYCLIN_1_8 8 11 RIKELRDLMSQSRT 9 [25]
MOD_GSK3_1_9 9 16 IKELRDLMSQSRTREILT 9 [25]
MOD_PIKK_1_9 9 15 IKELRDLMSQSRTREIL 9 [25]
LIG_PP1_44 44 50 QEKNPSLRVKWMMAMKY 44 [19,20,25,29]
MOD_CK2_1_63 63 69 TADKRIIETIPERNEQG 63, 64, 70 [16,20,25,27,31]
LIG_FHA_2_64 64 70 ADKRIIETIPERNEQGQ 63, 64, 70 [16,20,25,27,31]
MOD_GSK3_1_79 79 86 GQTLWSKMSDAGSDRVMV 81 [25]
MOD_PKA_2_79 79 85 GQTLWSRMSDAGSDRVM 81 [25]
MOD_PKA_2_104 104 110 WNRNGPRTSAVHYPKVY 105 [23,25,29]
LIG_SH3_3_106 106 112 RNGPMTSTVHYPKIYKT 105, 108 [23,29]
MOD_CK2_1_152 152 158 INPGHADLSAKEAQDVI 153, 156 [23,31]
LIG_SH2_STAT5_195 195 198 KEELQYCKIAPLMVA 199 [19,20,25,29]
TRG_ENDOCYTIC_2_195 195 198 KEELQYCKIAPLMVA 199 [19,20,25,29]
MOD_ProDKin_1_196 196 202 EELQDCKISPLMVAYML 199 [19,20,25,29]
MOD_PKA_1_268 268 274 ARNIVRRATVSADPLAS 271 [19,20,21,29,31]
MOD_PKA_2_268 268 274 ARNIVRRATVSADPLAS 271 [19,20,21,29,31]
MOD_GSK3_1_317 317 324 KAAMGLRISSSFSFGGFT 318 [15]
MOD_PKA_2_317 317 323 KAAMGLRISSSFSFGGF 318 [15]
LIG_14-3-3_2_318 318 324 AAMGLRISSSLSFGGFT 318 [15]
LIG_BRCT_BRCA1_1_319 319 323 AMGLRISSSFSFGGF 318 [15]
MOD_PKA_1_331 331 337 GGFTFKRTSGSSVKREE 333, 339 [22,31]
MOD_PKA_2_331 331 337 GGFTFKRTSGSSVKREE 333, 339 [22,31]
MOD_CK2_1_335 335 341 FKRTSGSSVKREEEVLT 333, 339, 341 [22,31]
MOD_CK2_1_336 336 342 KRTSGSSVTKEEEVLTG 333, 339, 341 [22,31]
LIG_FHA_2_336 336 342 KRTSGSSTKREEEVLTG 333, 339, 341 [22,31]
MOD_CK2_1_352 352 358 GNLQTLKLTVHEGYEEF 355 [15]
LIG_FHA_2_353 353 359 NLQTLKLTVHEGYEEFT 355 [15]
MOD_PKA_2_368 368 374 FTMVGRRATAILRKATR 368 [25]
MOD_PKA_1_368 368 374 FTMVGRRATAILRKATR 368 [25]
LIG_MAPK_1_476 476 485 TEMSMRGIRVSKMGVDEYSS 475 [19,20,25,29]
LIG_CYCLIN_1_476 476 480 TEMSMRGLRVSKMGV 475 [19,20,25,29]
LIG_FHA_2_481 481 487 RGVRVSKTGVDEYSSTE 482 [31]
TRG_NES_CRM1_1_492 492 506 EYSSTERIVVSIDRFLRVRDQRGNV 493 [29]
LIG_14-3-3_2_493 493 499 YSSTERVVVSIDRFLRV 493 [29]
MOD_ProDKin_1_530 530 536 ERLTITYSSPMMWEING 529, 530 [15]
LIG_PP1_559 559 565 IRNWEAVKIQWSQNPAM 567 [19,20,25,31]
MOD_GSK3_1_562 562 569 WETVKIQWSQDPTMLYNK 567, 569, 570 [19,20,25,29,31]
MOD_PIKK_1_562 562 568 WETVKIQWSQDPTMLYN 567, 569, 570 [19,20,25,29,31]
MOD_PIKK_1_587 587 593 SLVPKAIRSQYSGFVRT 588, 591 [19,20,21,24,25]
MOD_PKA_2_590 590 596 PKATRSRYSGFVRTLFQ 588, 591 [19,20,21,24,25]
MOD_PIKK_1_610 610 616 DVLGTFDTTQIIKLLPF 611, 613 [19,25,29,31]
MOD_GSK3_1_659 659 666 SPVFNYNKATKRLTVLGKD 661 [25,29]
MOD_PIKK_1_659 659 665 PVFNYNKATQRLTVLGK 661 [25,29]
MOD_PKA_2_659 659 665 PVFNYNRATKRLTVLGK 661 [25,29]
LIG_CYCLIN_1_663 663 667 YNKATKRLTVLGKDA 661 [25,29]
MOD_PKA_1_663 663 669 YNKATKRLTVLGKDAGA 661 [25,29]
MOD_PKA_2_663 663 669 YNKATKRLTVLGKDAGA 661 [25,29]
MOD_CK2_1_671 671 677 TILGKDAGTLIEDPDES 674 [20,25]
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function motifs in viral proteins.
In total, 67 locations with overlapping SLiMs were identified
among the 292 highly conserved SLiMs in RNPs (red rectangles in
Information S6, S11, S16, S21). These overlapping SLiMs may act
together through three mechanisms. First, multiple SLiM interac-
tions may be used cooperatively to increase the specificity and
strength with which two proteins bind to each other. Second,
multiple SLiMs may enable interaction between different cellular
signals sequentially. For example, the function of the first SLiM
may lead to the action of the second SLiM. Third, multiple SLiMs
may also enable the interaction between different cellular signals
competitively. A protein may contain different SLiMs that target
the same amino acid residue for different post translational
modifications as inputs from different cellular signals. This could
lead to competition (i.e. an interaction) between the two signals,
with different enzymes competing to modify the same residue. The
different post translational modification states of the motif could
bind to different interaction domains and result in different output
signals from the interaction.
The SLiMs which have a very low occurrence in RNPs from
human IAVs but present in RNPs from HP IAVs could be
candidates for novel virulent determinants that are worthy to be
further investigated. For example, 10 SLiMs (LIG_SPAK-
OSR1_1_204, MOD_PIKK_1_274 and MOD_GSK3_1_402 in
PA proteins; MOD_PAK_2_429 and LIG_MAPK_1_584 in PB1
proteins; MOD_PKA_1_268, MOD_PKA_2_268 and LIG_14-3-
3_2_555 in PB2 proteins; and LIG_MAPK_1_98 and
LIG_BRCT_BRCA1_1_309 in NP proteins) have a very low
occurrence in RNPs from human IAVs but have a high
occurrence in RNPs from avian and mammalian IAVs. Moreover,
all 10 of the SLiMs were found in RNPs from HP IAVs
(Information S9, S14, S19, S24). Therefore, they may represent
emerging SLiMs in RNPs of avian IAV origin which are in the
early stage of adaptation to human hosts. Another type of SLiMs
that have a low occurrence in RNPs from avian, human and
mammalian IAVs but are present in HP IAVs may also be
potential virulent determinants that occurred by coincidence
(Information S9, S14, S19, S24).
Many proteins are regulated by post-translational modifications
(PTMs) that may mediate allosteric effects or create binding sites
important for protein-protein interactions where ligand domains
can bind to phosphorylated, methylated or sumoylated sites. As
described for the ELM server, SLiMs can be classified into four
types of functional sites: ligand sites (LIG), PTM sites (MOD),
proteolytic cleavage and processing sites (CLV), and sites for
subcellular targeting (TRG) [3]. These functional assignments are
useful in that they encompass the range of peptide motif activities.
Furthermore, they can also help explain why many amino acid
sites have been experimentally demonstrated to be functionally
important for RNPs but do not have corresponding SLiMs in this
study. For example, the glutamic acid at PB2 position 627 is
generally found in avian viruses, whereas nearly all human isolates
carry a lysine at this position [36]. Available data suggests that PB2
position 627 determines the temperature sensitivity of vRNA
replication [37]. Viruses with PB2 627K can efficiently replicate in
the mammalian upper respiratory tract, whereas those that possess
PB2 627E cannot [38]. A PB2 E627K mutation enhances avian
virus replication in mammalian cells at 33uC, but not at 37uCo r
41uC, in vitro [37]. A lack of a corresponding SLiM suggests the
cold sensitivity of avian virus polymerases with PB2 627E may be
because the global domain conformation changes in the PB2
protein are directly affected by the residue itself rather than
mediated by a gain or loss of a post-translational modification
target site (SLiM).
To validate the putative SLiMs identified in this study several
experimental methods can be used. The first method is the reverse
genetics technology that is generally used for validation of IAV
protein function/activity affected by different amino acid muta-
tions [39,40]. The reverse genetics can be coupled with different
function assays. For example, to validate the influence of a SLiM
in virulence, virus particles produced by reverse genetics can be
used to infect model animals (mouse, ferret, swine or primate). The
survival rate, pathological changes, cytokine levels in blood could
be measured [41,42]. Interactions between IAV RNPs and known
host factors through SLiMs (e.g. LIG_SH2_STAT5 and LIG_-
TRAF2) identified in this study can be validated by biomolecular
fluorescence complementation (BiFC) [43,44] and split luciferase
complementation assay (SLCA) [45]. Localization of RNPs
Table 4. Cont.
SLiMs identified in this study Start End SLiM sequences Amino acid References
TRG_LysEnd_APsAcLL_1_671 671 676 TILGKDAGTLIEDPDE 674 [20,25]
LIG_FHA_2_672 672 678 VLGKDAGTLTEDPDEGT 674 [20,25]
MOD_CK2_1_681 681 687 IEDPDESTSGVESAVLR 680, 682, 684 [19,29,31]
MOD_GSK3_1_681 681 688 TEDPDEGTSGVESAVLRG 680, 682, 684 [19,29,31]
LIG_FHA_2_682 682 688 EDPDEGTTGVESAVLRE 680 682, 684 [19,29,31]
LIG_APCC_KENbox_2_698 698 702 GFLILGKENKRYGPA 698, 701, 702 [15,17,19,20,21,22,23,25,29,30,31]
LIG_MAPK_1_702 702 710 LGKEDKRYGPALSINELSN 701, 702 [15,17,19,20,21,22,23,25,29,30,31]
MOD_CK2_1_714 714 720 SINELSNLTKGEKANVL 714 [22]
LIG_FHA_2_715 715 721 INELSNLTKGEKANVLI 714 [22]
MOD_SUMO_717 717 720 ELSNLAKGEKANVL 714 [22]
MOD_GSK3_1_738 738 745 LVMKRKRDSSILTDSQTA 740 [29]
MOD_PKA_2_738 738 744 LVMKRKRDSSILTDSQTA 740 [29]
MOD_PKA_1_738 738 744 LVMKRKRDSSILTDSQT 740 [29]
MOD_GSK3_1_742 742 749 RKRDSSILTDSQTATKRI 740 [29]
doi:10.1371/journal.pone.0038637.t004
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and nuclear localization signal can be validated by fluorescence
recovery after photobleaching (FRAP) [46]. Specific modification
such as sumoylation can be validated by immunoblot of SUMO
specific antibody [47,48].
Using protein-protein interactions as targets for antiviral
chemotherapy has been proposed over a decade [49]. Currently,
this idea is considered in development of antiviral drugs for
flaviviruses and HIV [50,51]. To interfere in protein-protein
interactions, using peptides that mimic the interaction motifs is one
of the most straightforward approaches [52]. Several reports
demonstrated that peptide-mediated interference in IAV poly-
merase complex assembly can attenuate IAV replication [53–57].
SLiMs such as PDZ motif [58], LIG_SH2_GRB2 [59] are being
explored as drug targets. Since viruses have evolved to use motifs
for essential functions by hijacking host proteins [60], identifica-
tion of SLiMs which mediate interactions between viral protein
and host factors may provide valuable and specific information for
development of motif mimetic drugs to perturb the interactions to
treat virus infections [2].
Inhibition of interactions between viral proteins has the
advantage of high specificity and low side effect. However,
resistant strains may appear from fast co-evolution of RNA virus
proteins under selection pressures. The possibility of co-evolution
Table 5. SLiMs mapped to the vicinity of amino acids that were reported as genetic signatures or are associated with the
adaptation of IAV NP proteins to the host.
SLiMs identified in this study Start End SLiM sequences Amino acid References
TRG_ENDOCYTIC_2_10 10 13 GTKRSYEQMETGGE 9 [23]
MOD_CK2_1_12 12 18 KRSYEQMETGGERQDAT 9, 16 [19,20,23,25]
MOD_PKA_2_18 18 24 METDGERQTATEIRASV 16 [19,20,25]
LIG_SH2_STAT5_78 78 81 ERRNKYLEEHPSAG 77 [29]
LIG_MAPK_1_98 98 110 GGPIYRRRDGKWMRELILYDKEE 100 [19,25]
LIG_Actin_WH2_2_101 101 119 IYRRVDGKWMRELILYDKEELRRVWRQAN 100, 101, 102 [19,25,29]
LIG_MAPK_1_102 102 110 YKRVDRKWMRELVLYDKEE 100, 101, 102 [19,25,29]
LIG_CYCLIN_1_106 106 110 DGKWMRELILYDKEE 109 [19]
MOD_GSK3_1_127 127 134 QANNGEDATAGLTHIMIW 131 [29]
MOD_PKA_2_212 212 218 WRGENGRRTRIAYERMC 214 [19,25]
MOD_CK2_1_214 214 220 GENGRKTRSAYERMCNI 214 [19,25]
MOD_CK2_1_284 284 290 RESRNPGNTEIEDLIFL 283 [19,20,25,29]
LIG_14-3-3_2_292 292 298 GHDFEREGYSLVGIDPF 291, 293 [19,23]
LIG_AP2alpha_2_302 302 304 SLVGIDPFKLLQN 305 [19,20,25,29]
MOD_PIKK_1_307 307 313 DPFRLLQNSQVFSLIRS 305 [19,20,25,29]
MOD_GSK3_1_307 307 314 DPFRLLQNSQVFSLIRSN 305 [19,20,25,29]
TRG_ENDOCYTIC_2_313 313 316 QNSQVYSLIRPNEN 313 [19,20,25]
LIG_APCC_KENbox_2_318 318 322 YSLIRPKENPAHKSQ 319 [22]
MOD_GSK3_1_319 319 326 SLIRPKENSAHKSQLVWM 319 [22]
LIG_BRCT_BRCA1_1_334 334 338 VWMACHSAAFEDLRV 335 [29]
LIG_14-3-3_3_334 334 339 VWMACHSASFEDLRVS 335 [29]
LIG_FHA_2_335 335 341 WMACHSATFEDLRVSSF 335 [29]
MOD_ProDKin_1_350 350 356 SFIRGTKVSPRGKLSTR 353 [23,29]
LIG_CYCLIN_1_351 351 354 FIRGTRVLPRGKLS 353 [23,29]
MOD_PKA_2_356 356 362 KVSPRGRLSTRGVQIAS 357 [19,20,25,29]
LIG_Actin_WH2_2_367 367 384 GVQIASNENMDNMGSGTLELRSGYWAIR 365 [23]
MOD_GSK3_1_370 370 377 IASNENMETMDSSTLELR 372, 375, 377 [19,23,25,29]
MOD_CK2_1_374 374 380 ENMDNMGSSTLELRSGY 372, 375, 377 [19,23,25,29]
LIG_FHA_2_375 375 381 NVEAMDSTTLELRSRYW 375, 377 [23,25,29]
MOD_PKA_2_421 421 427 RSLPFERATIMAAFTGN 422, 423, 425 [19,25,29]
MOD_GSK3_1_450 450 457 IRMMEGAKTEEVSFRGRG 450, 455 [19,23]
LIG_TRAF6_451 451 459 RMMEGAKPEEVSFQGRGVF 450, 455 [19,23]
MOD_SUMO_451 451 454 RMMEGAKPEEVSFQ 450, 455 [19,23]
LIG_CtBP_453 453 457 MESAKPEDLSFQGRG 455 [19]
LIG_14-3-3_3_470 470 475 ELSDEKATSPIVPSFD 472 [29]
MOD_ProDKin_1_470 470 476 ELSDEKATSPIVPSFDM 472 [29]
LIG_SH3_3_471 471 477 LSDEKATNPIVPSFDMS 472 [29]
doi:10.1371/journal.pone.0038637.t005
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ELM Identifier Description GO_ID GO_Process RNPs
CLV_PCSK_FUR_1 The furin cleavage site GO:0006508 Proteolysis And Peptidolysis PB1
LIG_14-3-3_1 The 14-3-3 protein interacting motif GO:0007243 Protein Kinase Cascade PA, PB2
LIG_14-3-3_2 The 14-3-3 protein interacting motif GO:0007243 Protein Kinase Cascade PA, PB1, PB2, NP
LIG_14-3-3_3 The 14-3-3 protein interacting motif GO:0007243 Protein Kinase Cascade PA, PB1, PB2, NP
LIG_Actin_WH2_2 The actin interacting motif GO:0008064 Regulation Of Actin Polymerization
Or Depolymerization
PA, PB2, NP
LIG_AGCK_PIF_1 The PIF motif interacting motif GO:0007165 Signal Transduction PB2
LIG_AP2alpha_2 The AP2 complex interacting motif GO:0006897 Endocytosis PA, NP
LIG_APCC_Dbox_1 The APC/C complex interacting motif GO:0043161 Proteasomal Ubiquitin-Dependent
Protein Catabolic Process
PA, PB1, PB2
LIG_APCC_KENbox_2 The APC/C complex interacting motif GO:0043161 Proteasomal Ubiquitin-Dependent
Protein Catabolic Process
PA, PB2, NP
LIG_BRCT_BRCA1_1 The BRCT domain interacting motif GO:0000077 Dna Damage Checkpoint PA, PB1, PB2, NP
LIG_Clathr_ClatBox_1 The N-terminus of Clathrin heavy chain
interacting motif
GO:0006897 Endocytosis NP
LIG_CtBP The CtBP protein interacting motif GO:0045449 Regulation Of Transcription PA, NP
LIG_CYCLIN_1 Cyclin interacting motif GO:0007049 Cell Cycle PA, PB1, PB2, NP
LIG_EH_1 EH domain interacting motif GO:0006897 Endocytosis PB1
LIG_FHA_2 FHA domain interacting motif GO:0045449 Regulation Of Transcription PA, PB1, PB2, NP
LIG_HCF-1_HBM_1 the Host Cell Factor-1 interacting motif GO:0045449 Regulation Of Transcription PB2
LIG_HP1_1 HP1 protein interacting motif GO:0006343 Establishment Of Heterochromatin
Silencing
PA, PB2
LIG_MAD2 Mad2 interacting motif GO:0007094 Mitotic Spindle Checkpoint PB2
LIG_MAPK_1 MAPK interacting motif GO:0007243 Protein Kinase Cascade PA, PB1, PB2, NP
LIG_NRBOX Nuclear receptor interacting motif GO:0045449 Regulation of Transcription PA
LIG_PDZ_Class_2 The C-terminal class 2 PDZ-binding motif GO:0007165 Signal Transduction NP
LIG_PP1 The Protein phosphatase 1 catalytic subunit
interacting motif
GO:0007165 Signal Transduction PA, PB1, PB2
LIG_PTB_Apo_2 The Dab-like PTB domain interacting motif GO:0007169 Transmembrane Receptor Protein
Tyrosine Kinase Signalimg Pathway
PA, PB1
LIG_PTB_Phospho_1 The Shc-like and IRS-like PTB domain
interacting motif
GO:0007169 Transmembrane Receptor Protein
Tyrosine Kinase Signalimg Pathway
PA, PB1
LIG_RGD The RGD motif binding motif GO:0007155 Cell-Adhesion PB1, PB2, NP
LIG_SH2_GRB2 The GRB2-like Src Homology 2 (SH2) domain
binding motif
GO:0007165 Signal Transduction PA, PB1, PB2
LIG_SH2_SRC The Src-family Src Homology 2 (SH2) domains
binding motif
GO:0007165 Signal Transduction PA, PB2
LIG_SH2_STAT3 The STAT3 SH2 domain interacting motif GO:0045449 Regulation Of Transcription PB1
LIG_SH2_STAT5 The STAT5 SH2 domain binding motif GO:0045449 Regulation Of Transcription PA, PB1, PB2, NP
LIG_SH3_3 The SH3 domain interacting motif GO:0007165 Signal Transduction PA, PB1, PB2, NP
LIG_SPAK-OSR1_1 SPAK/OSR1 kinase binding motif GO:0006468 Protein Amino Acid Phosphorylation PA, NP
LIG_SxIP_EBH_1 The EBH domain interacting motif GO:0031535 Plus-End Directed Microtubule Sliding PB1, NP
LIG_TRAF2_1 TRAF2 binding motif GO:0007165 Signal Transduction PA, PB1, PB2, NP
LIG_TRAF6 TRAF6 binding motif GO:0007165 Signal Transduction PB1, PB2, NP
MOD_CDK_1 CDK phosphorylation site GO:0000308 Cycloplasmic Cyclin-Dependent
Protein Kinase Holoenzyme Complex
PA
MOD_CK2_1 CK2 phosphorylation site GO:0016055 Wnt Receptor Signaling Pathway PA, PB1, PB2, NP
MOD_GSK3_1 GSK3 phosphorylation site GO:0006468 Protein Amino Acid Phosphorylation PA, PB1, PB2, NP
MOD_PIKK_1 PIKK phosphorylation site GO:0000077 Dna Damage Checkpoint PA, PB1, PB2, NP
MOD_PKA_1 PKA-type AGC kinase phosphorylation site GO:0010737 Protein Kinase A Signaling Cascade PA, PB1, PB2
MOD_PKA_2 PKA-type AGC kinase phosphorylation site GO:0010737 Protein Kinase A Signaling Cascade PA, PB1, PB2, NP
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hand, is expected to be extremely low. Another concern is that the
inability of a synthetic peptide to penetrate cells precluded it from
therapeutic usefulness. Nevertheless, discovery of peptidomimetic
compounds can be pursued based on the structure of the effective
peptide.
In this study, the compositions of SLiMs (target sites of post-
translational modifications) of IAV RNPs were analyzed. Three
groups of SLiMs with different occurrences for each RNP were
found. The SLiMs identified in this study provide an invaluable
resource for experimental virologists to study the interactions
between IAV RNPs and host intracellular proteins. Moreover, the
SLiM compositions of IAV RNPs also provide insights into the
signal transduction pathways and protein interaction networks
with which IAV RNPs might be involved or interfere. The
information of SLiM mediated virus-host protein interactions
might be helpful for the development of anti-IAV drugs.
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